TRMT1 Antibodies

Santa Cruz Biotechnology delivers a wide array of TRMT1 monoclonal antibodies for investigating TRMT1 in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TRMT1, or tRNA methyltransferase 1, plays a crucial role in the post-transcriptional modification of tRNA, specifically in the methylation of adenosine residues. This modification is essential for proper tRNA functioning, which influences protein synthesis and cellular metabolism. TRMT1 has emerged as a significant factor in various biological pathways and disease mechanisms. Research has shown that TRMT1 modifications impact cellular homeostasis and protein translation efficiency. Understanding TRMT1's molecular mechanisms can provide valuable insights into cellular regulation and potential therapeutic approaches. Ongoing studies continue to reveal new aspects of TRMT1's biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of TRMT1's role in health and disease.